Human Endogenous Retroviruses and Hematological Malignant Tumors

Abstract. Human endogenous retrovirus (HERV) gene sequences are remnants of retroviruses that infected the ancestors of humans millions of years ago and were integrated into human chromosomes, accounting for approximately 8%–9% of the human genome. Most integrated HERVs have lost their coding capaci...

Full description

Bibliographic Details
Main Authors: Tianfu Li, Hanping Li, Lin Li, Jingyun Li, Yiming Shao
Format: Article
Language:English
Published: Wolters Kluwer Health 2022-06-01
Series:Infectious Microbes & Diseases
Online Access:http://journals.lww.com/10.1097/IM9.0000000000000090
_version_ 1818219185237393408
author Tianfu Li
Hanping Li
Lin Li
Jingyun Li
Yiming Shao
author_facet Tianfu Li
Hanping Li
Lin Li
Jingyun Li
Yiming Shao
author_sort Tianfu Li
collection DOAJ
description Abstract. Human endogenous retrovirus (HERV) gene sequences are remnants of retroviruses that infected the ancestors of humans millions of years ago and were integrated into human chromosomes, accounting for approximately 8%–9% of the human genome. Most integrated HERVs have lost their coding capacity and remain silent due to frame shifts, mutations, and sequence deletions or insertions over the millions of years, but their expression is highly regulated by epigenetic and host defense mechanisms. However, there are still some HERV genes that have intact open reading frames due to recent integration into the human genome or positive selective pressure. The abnormal activation of HERVs may contribute to diseases or their pathology, such as malignant tumors, autoimmune diseases, and nervous system diseases. The occurrence and development of hematological malignant tumors (HMTs) is a complex process involving interactions of multiple genetic and environmental factors. The abnormal activation of HERVs may contribute to the pathology of HMTs via indirect mechanisms. In this review, we address the discovery of endogenous retroviruses in vertebrates, and the classification and genomic structure of HERVs. Among HERV family members, HERV-K is the latest type of HERV integrated into the human genome and it has the strongest transcriptional activity. We explore the currently known expression of HERV-K proto-oncogenes in HMTs and further address potential research and therapeutic approaches. However, much remains to be learned about not only the impact of HERVs on the occurrence of HMTs, but also the potential value of HERVs as diagnostic and therapeutic targets for HMTs.
first_indexed 2024-12-12T07:35:38Z
format Article
id doaj.art-bca4cef62dad491e9034f66b39a53a91
institution Directory Open Access Journal
issn 2641-5917
language English
last_indexed 2024-12-12T07:35:38Z
publishDate 2022-06-01
publisher Wolters Kluwer Health
record_format Article
series Infectious Microbes & Diseases
spelling doaj.art-bca4cef62dad491e9034f66b39a53a912022-12-22T00:32:55ZengWolters Kluwer HealthInfectious Microbes & Diseases2641-59172022-06-0142566310.1097/IM9.0000000000000090202206000-00003Human Endogenous Retroviruses and Hematological Malignant TumorsTianfu Li0Hanping Li1Lin Li2Jingyun Li3Yiming Shao4Department of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.Department of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.Department of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.Department of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.Department of AIDS Research, State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.Abstract. Human endogenous retrovirus (HERV) gene sequences are remnants of retroviruses that infected the ancestors of humans millions of years ago and were integrated into human chromosomes, accounting for approximately 8%–9% of the human genome. Most integrated HERVs have lost their coding capacity and remain silent due to frame shifts, mutations, and sequence deletions or insertions over the millions of years, but their expression is highly regulated by epigenetic and host defense mechanisms. However, there are still some HERV genes that have intact open reading frames due to recent integration into the human genome or positive selective pressure. The abnormal activation of HERVs may contribute to diseases or their pathology, such as malignant tumors, autoimmune diseases, and nervous system diseases. The occurrence and development of hematological malignant tumors (HMTs) is a complex process involving interactions of multiple genetic and environmental factors. The abnormal activation of HERVs may contribute to the pathology of HMTs via indirect mechanisms. In this review, we address the discovery of endogenous retroviruses in vertebrates, and the classification and genomic structure of HERVs. Among HERV family members, HERV-K is the latest type of HERV integrated into the human genome and it has the strongest transcriptional activity. We explore the currently known expression of HERV-K proto-oncogenes in HMTs and further address potential research and therapeutic approaches. However, much remains to be learned about not only the impact of HERVs on the occurrence of HMTs, but also the potential value of HERVs as diagnostic and therapeutic targets for HMTs.http://journals.lww.com/10.1097/IM9.0000000000000090
spellingShingle Tianfu Li
Hanping Li
Lin Li
Jingyun Li
Yiming Shao
Human Endogenous Retroviruses and Hematological Malignant Tumors
Infectious Microbes & Diseases
title Human Endogenous Retroviruses and Hematological Malignant Tumors
title_full Human Endogenous Retroviruses and Hematological Malignant Tumors
title_fullStr Human Endogenous Retroviruses and Hematological Malignant Tumors
title_full_unstemmed Human Endogenous Retroviruses and Hematological Malignant Tumors
title_short Human Endogenous Retroviruses and Hematological Malignant Tumors
title_sort human endogenous retroviruses and hematological malignant tumors
url http://journals.lww.com/10.1097/IM9.0000000000000090
work_keys_str_mv AT tianfuli humanendogenousretrovirusesandhematologicalmalignanttumors
AT hanpingli humanendogenousretrovirusesandhematologicalmalignanttumors
AT linli humanendogenousretrovirusesandhematologicalmalignanttumors
AT jingyunli humanendogenousretrovirusesandhematologicalmalignanttumors
AT yimingshao humanendogenousretrovirusesandhematologicalmalignanttumors